Skip to main content

Table 1 Laboratory characteristics of the studied patients

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

Variable   AML group (n = 40)
TLC Median (IQR) 36.05 (2.5–70)
HGB Mean ± SD
Range
7.37 (1.62)
3.3–10.4
PLT Median (IQR) 22.5 (13.3–54.8)
BM blasts count Mean ± SD 74.53(17. 76)
FAB classification N (%)
 M0–M1 3 7.5%
 M1–M2 19 47.5%
 M3 10 25.0%
 M4 6 15.0%
 M5 2 5.0%
Cytogenetic findings
t(8,21) (q22;q22) 2/19 5%
t(15;17) (q22;q21) 5/10 12.5%
Inv. 16/t(16;16) (p13;q22) 1/4 2.5%
11q23 0/1 0
t(9;22) (q34;q11) 0/7 0
  1. TLC total leucocyte count, HGB hemoglobin, PLTs platelets, BM bone marrow, FAB French–American–British classification, SD standard deviation, IQR interquartile range